<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/2072-0351-6002</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-6002</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Применение биоокислительной терапии в лечении сахарного диабета</article-title><trans-title-group xml:lang="en"><trans-title>Primenenie biookislitel'noy terapii v lechenii sakharnogo diabeta</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Северина</surname><given-names>Анастасия Сергеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Severina</surname><given-names>Anastasia Sergeevna</given-names></name></name-alternatives><email xlink:type="simple">-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шестакова</surname><given-names>Марина Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Shestakova</surname><given-names>Marina Vladimirovna</given-names></name></name-alternatives><email xlink:type="simple">-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГУ Эндокринологический Научный Центр Росмедтехнологий, Москва</institution></aff><aff xml:lang="en"><institution>Endocrinology Research Centre, Moscow</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>15</day><month>09</month><year>2007</year></pub-date><volume>10</volume><issue>3</issue><issue-title>№3 (2007)</issue-title><fpage>66</fpage><lpage>68</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Северина А.С., Шестакова М.В., 2007</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="ru">Северина А.С., Шестакова М.В.</copyright-holder><copyright-holder xml:lang="en">Severina A.S., Shestakova M.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/6002">https://www.dia-endojournals.ru/jour/article/view/6002</self-uri><abstract><p>Широко рекламируемые в настоящее время методы биоокислительной терапии, в частности озонотерапия не имеют под собой необходимой и достаточной доказательной научной базы, и основная масса их важнейших постулатов является спекулятивной и не доказанной научно, носящей обобщающий характер, основана на работах, которые реально редко публикуются в рецензируемых журналах, поскольку имеют ряд недостатков, не позволяющих использовать их в качестве научнообоснованных результатов. Кроме того, подтвержденные побочные действия озонотерапии представляют существенную опасность для пациентов, значительно перевешивая даже гипотетические положительные эффекты. Таким образом, не подвергая сомнению некоторые положительные эффекты биоокислительной терапии при наружном применении, такие как местное антисептическое действие, широко рекомендовать эти средства для системного лечения не представляется возможным; это несет в себе опасность для жизни и здоровья больных.</p></abstract><kwd-group xml:lang="ru"><kwd>биоокислительная терапия</kwd><kwd>лечение</kwd><kwd>сахарный диабет</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Wentworth P.Jr., McDunn J.E., Wentworth A.D., Takeuchi C., Nieva J., Jones T., Bautista C., Ruedi J.M., Gutierrez A., Janda K.D., Babior B.M., Eschenmoser A., Lerner R.A. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science. 2002 Dec 13;298(5601):2195-9.</mixed-citation><mixed-citation xml:lang="en">Wentworth P.Jr., McDunn J.E., Wentworth A.D., Takeuchi C., Nieva J., Jones T., Bautista C., Ruedi J.M., Gutierrez A., Janda K.D., Babior B.M., Eschenmoser A., Lerner R.A. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science. 2002 Dec 13;298(5601):2195-9.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ishizaki K., Sawadaishi D., Miura K., Shinriki N. Effect of ozone on plasmid DNA of Escherichia coli in situ. Water Res 1987; 21(7): 823-828.</mixed-citation><mixed-citation xml:lang="en">Ishizaki K., Sawadaishi D., Miura K., Shinriki N. Effect of ozone on plasmid DNA of Escherichia coli in situ. Water Res 1987; 21(7): 823-828.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez-Sanchez G., Al-Dalain S., Mendez S. et al. Therapeutic efficacy of ozone in patients with diabetic foot // Eur J of Pharmacology, vol. 523, 1-3, 31 october 2005, pp. 151-161.</mixed-citation><mixed-citation xml:lang="en">Martinez-Sanchez G., Al-Dalain S., Mendez S. et al. Therapeutic efficacy of ozone in patients with diabetic foot // Eur J of Pharmacology, vol. 523, 1-3, 31 october 2005, pp. 151-161.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Di Paolo N., Bocci V., Salvo D. et al. Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease // Int J Artif Organs 2005 Oct; 28(10): 1039-50.</mixed-citation><mixed-citation xml:lang="en">Di Paolo N., Bocci V., Salvo D. et al. Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease // Int J Artif Organs 2005 Oct; 28(10): 1039-50.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Oepen I., Eisenmenger W., Schmitt H. Et al. Advantages and risks of ozone therapy // Offentl Gesundheitswes. 1983 Jul; 45(7) 323-6</mixed-citation><mixed-citation xml:lang="en">Oepen I., Eisenmenger W., Schmitt H. Et al. Advantages and risks of ozone therapy // Offentl Gesundheitswes. 1983 Jul; 45(7) 323-6</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gabriel C., et al. Transmission of Hepatits C by ozone enrichment of autologous blood // Lancet, 1996; 347: 541.</mixed-citation><mixed-citation xml:lang="en">Gabriel C., et al. Transmission of Hepatits C by ozone enrichment of autologous blood // Lancet, 1996; 347: 541.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Foksinski M., Bialkowski K., Skiba M. et al. Evaluation of 8-oxodeoxyguanosine, typical oxidative DNA damage, in lymphocytes of ozone-treated arteriosclerotic patients // Mutat Res. 1999 Jan 2; 438(1): 23-27.</mixed-citation><mixed-citation xml:lang="en">Foksinski M., Bialkowski K., Skiba M. et al. Evaluation of 8-oxodeoxyguanosine, typical oxidative DNA damage, in lymphocytes of ozone-treated arteriosclerotic patients // Mutat Res. 1999 Jan 2; 438(1): 23-27.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Questionable methods of cancer management hydrogen peroxide and ther «hyperoxygenation methods» //A cancer journal for clinicians1993 Vol. 43 No. 1 pp. 47-56.</mixed-citation><mixed-citation xml:lang="en">Questionable methods of cancer management hydrogen peroxide and ther «hyperoxygenation methods» //A cancer journal for clinicians1993 Vol. 43 No. 1 pp. 47-56.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
